 |
인쇄하기
취소
|
SeouLin seeks international hepatitis B test patent
SeouLin Bioscience, local biopharmaceutical firm, said it has filed an international patent application for detecting mutants of hepatitis B virus, a company official said.
The company's patent may be applicable in developing a specific chip by incorporating it with BioMEMS technology.
The domestic market for diagnostic reagents is estimated at 500 billion won at the yearend, with hepatit...
The company's patent may be applicable in developing a specific chip by incorporating it with BioMEMS technology.
The domestic market for diagnostic reagents is estimated at 500 billion won at the yearend, with hepatit...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.